These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21346244)

  • 1. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
    Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
    Coe LM; Lippner D; Perez GI; McCabe LR
    J Cell Biochem; 2011 Sep; 112(9):2403-11. PubMed ID: 21538476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
    Fader KA; Nault R; Raehtz S; McCabe LR; Zacharewski TR
    Toxicol Appl Pharmacol; 2018 Jun; 348():85-98. PubMed ID: 29673856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.
    Menon P; Yin G; Smolock EM; Zuscik MJ; Yan C; Berk BC
    J Cell Physiol; 2010 Nov; 225(3):777-85. PubMed ID: 20568227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
    Coe LM; Zhang J; McCabe LR
    J Cell Physiol; 2013 Apr; 228(4):689-95. PubMed ID: 22886636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
    Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
    J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
    Motyl KJ; McCauley LK; McCabe LR
    J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Botolin S; McCabe LR
    J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia.
    Lozano D; de Castro LF; Dapía S; Andrade-Zapata I; Manzarbeitia F; Alvarez-Arroyo MV; Gómez-Barrena E; Esbrit P
    Endocrinology; 2009 May; 150(5):2027-35. PubMed ID: 19196804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta.
    Carmona MC; Hondares E; Rodríguez de la Concepción ML; Rodríguez-Sureda V; Peinado-Onsurbe J; Poli V; Iglesias R; Villarroya F; Giralt M
    Biochem J; 2005 Jul; 389(Pt 1):47-56. PubMed ID: 15762841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone inflammation and altered gene expression with type I diabetes early onset.
    Motyl KJ; Botolin S; Irwin R; Appledorn DM; Kadakia T; Amalfitano A; Schwartz RC; McCabe LR
    J Cell Physiol; 2009 Mar; 218(3):575-83. PubMed ID: 19006181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
    Botolin S; Faugere MC; Malluche H; Orth M; Meyer R; McCabe LR
    Endocrinology; 2005 Aug; 146(8):3622-31. PubMed ID: 15905321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increase in bone resorption in early-stage type I diabetic mice is induced by RANKL secreted by increased bone marrow adipocytes.
    Yang J; Chen S; Zong Z; Yang L; Liu D; Bao Q; Du W
    Biochem Biophys Res Commun; 2020 Apr; 525(2):433-439. PubMed ID: 32102755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.
    Yoshioka S; Miura Y; Yao H; Satake S; Hayashi Y; Tamura A; Hishita T; Ichinohe T; Hirai H; Takaor-Kondo A; Maekawa T
    Stem Cells; 2014 Mar; 32(3):730-40. PubMed ID: 24115241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
    Coe LM; Tekalur SA; Shu Y; Baumann MJ; McCabe LR
    J Cell Physiol; 2015 Aug; 230(8):1944-53. PubMed ID: 25641511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
    Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
    J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.
    Schroeder-Gloeckler JM; Rahman SM; Janssen RC; Qiao L; Shao J; Roper M; Fischer SJ; Lowe E; Orlicky DJ; McManaman JL; Palmer C; Gitomer WL; Huang W; O'Doherty RM; Becker TC; Klemm DJ; Jensen DR; Pulawa LK; Eckel RH; Friedman JE
    J Biol Chem; 2007 May; 282(21):15717-29. PubMed ID: 17387171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.
    Maycas M; McAndrews KA; Sato AY; Pellegrini GG; Brown DM; Allen MR; Plotkin LI; Gortazar AR; Esbrit P; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):486-497. PubMed ID: 27683064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.
    Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C
    J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of phospholipase D1 decreases bone mass and increases fat mass via modulation of Runx2, β-catenin-osteoprotegerin, PPAR-γ and C/EBPα signaling axis.
    Kang DW; Hwang WC; Noh YN; Che X; Lee SH; Jang Y; Choi KY; Choi JY; Min DS
    Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166084. PubMed ID: 33497821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.